Decellularized Extracellular Matrices and Cardiac Differentiation: Study on Human Amniotic Fluid-Stem Cells

Area of Science:

• Cardiovascular regenerative medicine
• Biomaterials science
• Stem cell biology

Background:

• Cell therapy is a key strategy for cardiovascular disease (CVD) treatment.
• Decellularized extracellular matrices (dECMs) are promising scaffolds for cardiac tissue engineering.
• A transplantable scaffold is needed to support cardiac stem cell differentiation for preclinical studies.

Purpose of the Study:

• To evaluate decellularized extracellular matrices (dECMs) as scaffolds for cardiac differentiation of Cardiopoietic AF stem cells.
• To identify a transplantable scaffold for cardiovascular tissue engineering applications.

Main Methods:

• Cardiopoietic AF stem cells were cultured on two types of dECMs: porcine Cor™PATCH and equine MatrixPatch™.
• Cell proliferation and cardiac differentiation were assessed on the dECM scaffolds.
• The dECMs' suitability as transplantable scaffolds was evaluated.

Main Results:

• Both Cor™PATCH and MatrixPatch™ dECMs supported the proliferation of Cardiopoietic AF stem cells.
• These dECMs also promoted the cardiac differentiation of the stem cells.
• The dECMs proved to be effective transplantable scaffolds for stem cell delivery.

Conclusions:

• Decellularized extracellular matrices (dECMs) are effective scaffolds for supporting Cardiopoietic AF stem cell proliferation and cardiac differentiation.
• Porcine and equine dECMs are suitable for transplantation with stem cells in preclinical cardiovascular research.
• These findings pave the way for translating in vitro studies to animal models for cardiovascular regenerative medicine.